Reposted by Alison Huang, MD
Researcher Amita Gupta has spent more than a decade planning and running a $70-million trial to study a new tuberculosis drug, enrolling ~6,000 participants in 13 countries. It might all have been for nothing.
That's because a new NIH policy has abruptly cut off billions to trials abroad. 🧪
nature.com
NIH grant cuts will axe clinical trials abroad — and could leave thousands without care
US agency’s new policy could abruptly end studies of infectious diseases and cancer, leaving researchers scrambling for funds.